PFE · News · 20260923N

Product Launch and Transition

PFIZER INC · 2026-09-23 · Importance 31 · Surprise 42

Pfizer is refocusing its commercial model on newer and acquired medicines while reducing exposure to its COVID-19 franchise. The strategy redirects spending toward selected markets and products as newer offerings offset declining COVID-19 demand. Company executives described the approach as a rebuild of Pfizer’s commercial model around post-pandemic growth products.